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In Brief
Neural crest induction requires the
interplay of transcription factors and
signaling pathways at the neural plate
border. Simo˜es-Costa et al. implicate
Axud1, a downstream effector of Wnt
signaling, as an integrator of signaling
and transcriptional cues for neural crest
formation, through interaction with neural
plate border genes Pax7 and Msx1.
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Neural crest cells are induced at the neural plate
border by the combined action of transcription
factors and signaling molecules. Here, we show
that Axud1, a downstream effector of Wnt signaling,
represents a critical missing link that integrates
signaling and transcriptional cues to mediate neu-
ral crest formation. Axud1 is a transcription factor
expressed in neural crest progenitors in a Wnt1/
b-catenin-dependent manner. Axud1 loss leads
to downregulation of multiple genes involved in
neural crest specification, similar to the effects of
Wnt1 knockdown. Importantly, Axud1 is sufficient
to rescue neural crest formation after disruption of
Wnt signaling. Furthermore, it physically interacts
with neural plate border genes Pax7 andMsx1 in vivo
to directly activate transcription of stem cell factor
FoxD3, initiating the neural crest program. Thus,
Axud1 integrates Wnt signaling with transcriptional
inputs to endow the neural crest with its unique
molecular signature.
INTRODUCTION
The neural crest is a progenitor cell population that gives rise to
many defining features of vertebrates, including much of the pe-
ripheral nervous system, structural elements of the face and
pigmentation of the skin (Green et al., 2015; Le Douarin and
Kalcheim, 1999; Simo˜es-Costa and Bronner, 2013). The process
of neural crest induction begins during gastrulation and re-
quires the interplay of transcriptional regulators, receptors, and
signaling molecules at the neural plate border (Sauka-Spengler
and Bronner-Fraser, 2008; Simo˜es-Costa et al., 2014). Neural
crest formation is coordinated by a multistep neural crest gene
regulatory network (NC GRN), which comprises multiple signals
and transcriptional inputs that are active in the neural crest line-
age (Meulemans and Bronner-Fraser, 2002; Simo˜es-Costa and
Bronner, 2015).
Initiation of the NC GRN is thought to be driven by secreted
growth factors such as Wnts, BMPs, and FGFs, which induce
expression of a set of transcription factors at the border between
neural and non-neural ectoderm (Prasad et al., 2012). These neu-544 Developmental Cell 34, 544–554, September 14, 2015 ª2015 Elsral plate border specifier genes, including Pax7 (Basch et al.,
2006) and Msx1 (Monsoro-Burq et al., 2005), are critical for
neural crest formation and directly activate transcription of
bona fide neural crest markers like FoxD3 (Simo˜es-Costa et al.,
2012). It has been proposed that the border specifier genes
cooperate with signaling events, and in particular the Wnt
pathway (Garcı´a-Castro et al., 2002; Ikeya et al., 1997; LaBonne
and Bronner-Fraser, 1998), to mediate neural crest specification
(Sauka-Spengler and Bronner-Fraser, 2008; Simo˜es-Costa and
Bronner, 2015). However, the molecular mechanism through
which these different tiers of regulation are integrated to activate
the neural crest molecular program has remained elusive.
Here, we probe how signaling and transcriptional inputs are
coordinated during neural crest formation, focusing on the Wnt
pathway. Our results show that Axud1 (also known as Csrnp1),
proposed to be a Wnt effector, is critical for linking Wnt signaling
with transcriptional regulators at the neural plate border to
mediate neural crest specification. Axud1 was first uncovered
in a microarray screen designed to identify Wnt targets of
Axin1-induced LoVo colon cancer cells (Ishiguro et al., 2001).
We show that Axud1 expression in neural crest precursors is
controlled by Wnt signaling and that its loss in turn abrogates
expression of multiple neural crest genes. Furthermore, Axud1
physically interacts with Msx1 and Pax7 at the neural plate
border to directly activate transcription of FoxD3, one of the
earliest markers of premigratory neural crest cells. These results
clarify how signaling pathways are integrated with the tran-
scriptional machinery to allow for emergence of nascent neural
crest stem cells, uncovering a mechanism through which Wnt
signaling functions in the induction of the neural crest.
RESULTS
Expression Pattern of Axud1 in the Early Chick Embryo
We identified transcriptional regulator Axud1 as a neural crest
marker that is expressed in the neural plate border as well as
in the dorsal neural folds (Figure 1). In the chick embryo, Axud1
expression was first detectable during gastrulation in Hensen’s
node and the paraxial mesoderm (Figures 1A and 1B). At
Hamburger and Hamilton stage (HH) 7, Axud1 was robustly ex-
pressed in the neural folds as they began to elevate (Figure 1C).
Expression was enhanced in the dorsal neural tube at stages
HH8–9 (Figure 1D) and persisted in early migratory neural crest
cells (Figures 1E–1G). At stage HH10, Axud1 transcripts were
detected in cranial and vagal neural crest cells (Figure 1H).
In addition to the neural folds and neural crest cells, Axud1evier Inc.
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Figure 1. Axud1 Is a Marker of the Premigra-
tory Neural Crest in Chick Embryos
All embryos are shown from a dorsal aspect.
(A and B) In situ hybridization showed Axud1
expression in the Hensen’s node (A) and the par-
axial mesoderm (B) in gastrulating chick embryos.
(C–E) At neurula stages, Axud1 transcripts were
detected in the dorsal neural folds (NFs) as they
elevate and converge to form the neural tube.
(F and G) Cross-sections of neurula stage embryos
showed specific expression of Axud1 in the dorsal
neural tube.
(H) At later stages, Axud1 was expressed in
the early migrating neural crest (NC) and other
structures targeted by Wnt signaling such as the
mesonephros (MN) and the first presumptive
somite.
(I–L) Double in situ hybridization for Axud1 (I) and
FoxD3 (J) revealed co-expression of both genes in
the premigratory (K) and early migrating cranial
neural crest (L).
(M) Onset of FoxD3 expression was observed at
HH8 within the Axud1 expression domain.
(N) Expression of Axud1 in neural crest progenitors
initiates after the establishment of the neural plate
border but before neural crest gene expression,
making it a likely candidate regulator in neural crest
formation.
HH, Hamburger and Hamilton developmental
stages; HH, Hensen’s node; MN, mesonephros;
NF, neural folds; NC, neural crest; PM, paraxial
mesoderm; R, rhombomere; SS, somites; VNC,
vagal neural crest.expression was observed in the first presumptive somite (Fig-
ure 1C), mesonephros (Figure 1H), and cardiac cushion, consis-
tent with previous observations suggesting that Wnt signaling is
ongoing in these tissues (Ku¨hl, 2003).
To determine its position in the NC GRN relative to other tran-
scription factors involved in neural plate border and neural crest
specification, we performed double fluorescent in situ hybridiza-
tion of Axud1 and FoxD3, one of the earliest expressed neural
crest specifier genes and critical for initiating the neural crest
program (Simo˜es-Costa et al., 2012). The results showed that
Axud1 is co-expressed with FoxD3 in the cranial region in both
the premigratory (Figures 1I–1K) and early migrating (Figure 1L)
neural crest. At HH8, when FoxD3 appears, Axud1 preceded
but then overlapped with FoxD3 (Figure 1M), although it was
expressed in regions of the neural axis where FoxD3 is
later missing, like rhombomere (R) 3 and R5 (Figure 1L). Thus,
Axud1 co-localizes with both neural plate border and neuralDevelopmental Cell 34, 544–554, Screst specifier genes. Importantly, the
onset of FoxD3 expression takes place
within the Axud1-positive territory in the
neural folds (Figure 1M). Taken together
with previous data on the expression of
chick neural crest genes (Betancur et al.,
2010; Khudyakov and Bronner-Fraser,
2009; Simo˜es-Costa et al., 2012), the re-
sults show that Axud1 expression initiates
after neural plate border genes Pax7 andMsx1, but prior to neural crest specifier genes like FoxD3 and
Sox10 (Figure 1N). In conclusion, Axud1 is expressed at the cor-
rect time and place to be involved in neural crest specification.
Loss of Function of Axud1 Blocks Expression of Early
Neural Crest Specifier Gene, FoxD3
To test the role of Axud1 in neural crest specification, we per-
formed loss-of-function assays using three different strategies:
a translation-blocking morpholino, a splice-blocking morpho-
lino, and a dominant-negative (DN) construct, all of which yielded
similar results. These were individually electroporated into the
right side of HH5+ chick embryos, after establishment of the neu-
ral plate border but before onset of Axud1 expression, while the
left sidewas electroporatedwith control constructs/morpholinos
(Figure 2A). Following electroporation, embryos were grown until
premigratory neural crest stages (Figure 2B), and gene expres-
sion on the experimental side (right) was compared to the controleptember 14, 2015 ª2015 Elsevier Inc. 545
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Figure 2. Axud1 Is Necessary for FoxD3
Expression
(A and B) Diagram of electroporation assays
for loss-of-function experiments. (A) Control
(blue) and targeted (green) reagents were in-
jected in different sides of gastrulating embryos.
(B) Following injection, embryos were electro-
porated and cultured until the desired stages.
Phenotypes were scored by comparing the control
and experimental sides of the same embryo.
(C and D) Immunohistochemistry with an Axud1
antibody shows loss of the Axud1 protein in
dorsal neural folds electroporated with Axud1
morpholino.
(E–H) Morpholino-mediated knockdown of Axud1
resulted in a marked reduction of endogenous
FoxD3 expression (E and F), as well as loss in
activity of the NC1 enhancer, which controls
cranial expression of FoxD3 (Simo˜es-Costa et al.,
2012) (G and H).
(I and J) Quantitation of embryos following loss-
of-function assays. The total number of embryos
analyzed for each experiment is represented in
parenthesis. See Figure S1 for additional controls
of loss of function experiments.
CoMo, control morpholino; Axud1DN, Axud1 DN;
Axud1SBMo, Axud1 splice-blocking morpholino;
Axud1TBMo, Axud1 translation-blocking mor-
pholino; HH, Hamburger and Hamilton develop-
mental stages.side (left). Electroporation of both targeted morpholinos resulted
in strong knockdown of the Axud1 protein in the dorsal neural
folds when compared with the control side (Figures 2C and
2D). To further demonstrate specificity, we performed rescue ex-
periments, in whichmorpholinos were co-electroporated with an
Axud1 expression vector. Whereas electroporation of the Axud1
expression vector was not sufficient to induce ectopic neural
crest formation in other regions of the neural tube, it attenuated
the loss of FoxD3 expression observed in Axud1 morpholino-
treated embryos (Figures S1A–S1G). We also verified that
Axud1 knockdown did not alter the amount of cell death in elec-
troporated embryos by conducting immunohistochemistry with
an anti-active Caspase-3 antibody (Figures S1H–S1L).
We analyzed the effects of Axud1 loss of function on neural
crest specification by examining its requirement for expression
of FoxD3, the first neural crest specifier gene to be transcribed
in chick embryos (Simo˜es-Costa et al., 2012). Electroporation
of either antisense morpholinos or DN Axud1 led to elimination
of endogenous FoxD3 in the cranial neural folds (Figures 2E
and 2F). Each of the two different morpholinos had a stronger
effect than the DN construct, likely because the latter must
compete with endogenous protein. Next, we assayed the effects
of Axud1 knockdown on reporter expression driven by the NC1
enhancer, which mediates FoxD3 expression in the cranial
neural crest (Simo˜es-Costa et al., 2012). Similar to what was
observed for endogenous FoxD3 expression, enhancer activity
was lost following Axud1 knockdown (Figures 2G and 2H). All
three approaches for loss of function resulted in downregulation546 Developmental Cell 34, 544–554, September 14, 2015 ª2015 Elsevier Inc.of FoxD3 expression and loss of enhancer
activity (Figures 2I and 2J). These results
indicate that expression of Axud1 in theneural plate border is required for the onset of neural crest
specification.
Axud1 Is a Direct Input into the FoxD3 Enhancer, NC1
Since loss of Axud1 abrogates expression driven by the FoxD3
NC1 enhancer element, we askedwhether Axud1 is a direct tran-
scriptional regulator of FoxD3, as previously shown for neural
plate border genes Pax7 and Msx1 (Simo˜es-Costa et al., 2012).
Axud1 is a member of the Cysteine-Serine Rich Nuclear Protein
family and interacts with DNA through the consensus binding
sequence AGAGTS (Gingras et al., 2007). Intriguingly, analysis
of the NC1 sequence revealed an Axud1 binding site located be-
tween the Hox (Pax7) and the Msx1 binding sites necessary for
enhancer activity (Simo˜es-Costa et al., 2012) (Figure 3A).
Consistent with the possibility that Axud1 is a direct input into
FoxD3, mutation of the Axud1 site resulted in strong loss of
enhancer activity in electroporated embryos (Figures 3B–3F).
While co-electroporation of two constructs with the NC1
enhancer driving either mCherry or GFP in the same embryo
result in equivalent levels of expression (Figures 3B and 3C),
the vector carrying a mutation in the Axud1 binding side
(mut:NC1:eGFP) exhibited striking loss of activity when
compared with the WT version (Figures 3D and 3E). Indeed,
quantification of reporter genes by qPCR showed a 5-fold reduc-
tion in expression driven by the mutated construct relative to the
WT vector (Figure 3F).
Finally, we performed chromatin immunoprecipitation (ChIP)
in dissected dorsal neural folds to explore whether Axud1 binds
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Figure 3. Axud1 Is a Direct Regulator of
Neural Crest Specifier Gene FoxD3
(A) The NC1 enhancer core contains an Axud1
binding site between Pax7 and Msx1 sites.
(B and C) Co-electroporation of a NC1 enhancer
driving mCherry (NC1:mCherry) and an NC1
enhancer encoding eGFP (NC1:eGFP) result in
similar levels of reporter gene expression in the
same embryo.
(D and E) Alternatively, co-electroporation of a
NC1:mCherry with a mutated Axud-binding site
encoding GFP (mut:NC1:eGFP) indicate the
construct harboring the mutation (E) has negligible
activity when compared with the WT mCherry
vector (D).
(F) Quantitation of reporter gene expression levels
through qPCR confirmed mutation of the Axud1
binding site results in loss of NC1 enhancer activity.
Reporter gene levels are represented relative to
GAPDH expression.
(G) ChIP assay performed in dissected dorsal
neural folds of stage HH9 embryos electroporated
with a FLAG-tagged Axud1 expression construct.
IP of the Axud1 protein with an anti-FLAG antibody,
followed by site specific qPCR with primer pairs
designed to amplify two fragments within the NC1
region (NC1a and NC1b) revealed significant
enrichment of the NC1 region in the Axud1
pull-down when compared to IGG controls. No
enrichment was observed for a negative control
region upstream of the FoxD3 locus in the chicken
chromosome 8 (NEG). Enrichment of amplicons
is expressed as a percent of the total input chro-
matin used in the IP assay. Error bars on (F) and (G)
represent SD.to the NC1 enhancer. The assay revealed that Axud1 directly
interacts with this element (Figure 3G) in vivo. In summary,
enhancer analysis places Axud1 as a direct regulator of neural
crest specification that is expressed after establishment of the
neural plate border and thus occupies an intermediate position
in the NC GRN.
Axud1 Is a Regulator of Multiple Neural Crest Specifier
Genes
To assay whether Axud1 is a specific input for FoxD3 or more
broadly regulates the neural crest specification program, we
investigated how its loss impacts other members of the neural
crest specifier module. In addition to FoxD3, Axud1 knockdown
caused loss of expression of numerous neural crest specifier
genes, including Sox9, Sox10, and Ets1, but not neural plate
border genePax7 (Figures 4A–4H). Multiplex Nanostring analysis
(Figures 4I and 4J), which enabled quantitative analysis of tran-
script levels of hundreds of genes simultaneously, confirmed
that Axud1 knockdown caused loss of neural crest specifier
genes in the neural folds (Figure 4K). Interestingly, this analysis
revealed upregulation of genes important for placodal and CNS
development, concomitant with loss of neural crestmarkers (Fig-
ure 4K). This suggests that Axud1 drives neural plate border cells
to a neural crest identity at the expense of neural and placodal
fates. Consistent with this, immunostaining with the Sox2 anti-
body revealed a striking expansion of the neural marker into
the neural crest forming region of the dorsal neural tube afterDevelopmenAxud1 knockdown (Figures S2A and S2B). In addition, we
observed a medial expansion of the placodal marker Six1 into
the dorsal neural tube (Figures S2A and S2C). Indeed, without
Axud1, cranial neural crest cells fail to delaminate from the neural
tube (Figure 4L) to become migratory (Figures 4M and 4N). The
results indicate that Axud1 acts as a critical regulator of genes
involved in neural crest specification, such that its loss of function
causes a global loss of neural crest specifier gene expression.
Axud1 Rescues Neural Crest Formation Caused by Loss
of Wnt1 or b-Catenin
Axud1 has been proposed to be a Wnt target gene based on
studies in cell lines and chick embryos (Ishiguro et al., 2001;
Quinlan et al., 2009). Therefore, we tested the hypothesis that
Axud1 is downstream of Wnt signaling in the dorsal neural folds.
Immunohistochemistry with a Wnt1 antibody revealed that
Axud1 is expressed within the Wnt1 domain in the dorsal neural
tube (Figures 5A and 5B). To test whether Wnt1 is an activator of
Axud1, we disrupted Wnt signaling using morpholinos targeted
to Wnt1 (Figures 5C and 5F) and b-catenin (Figures 5D and 5G)
or a DN Wnt1 construct. Knockdown of Wnt1 by any of these
methods resulted in loss of Axud1 expression (Figure 5M).
Conversely, overexpression of Wnt1 increased Axud1 transcrip-
tion (Figures 5E–5H). Although confirmation of the direct control
of Axud1 enhancers by TCF/Lef will require in-depth cis-regula-
tory analysis of this gene, these data indicate that Axud1 is
downstream of Wnt signaling.tal Cell 34, 544–554, September 14, 2015 ª2015 Elsevier Inc. 547
Figure 4. Axud1 Is Required for Neural Crest
Formation
(A–D) Whole-mount views of embryos after Axud1
morpholino (AXUD1SBMo) were introduced on the
right (green) and control morpholino (CoMo) on the
left (blue) of each embryo.
(E–H) The same embryos as above after in situ
hybridization for the indicated gene, with down-
ward blue arrows indicating downregulation.
Knockdown of Axud1 caused loss of neural crest
specifier genes, including Sox10 (E), Ets1 (F), and
Sox9 (G), while neural plate border specifiers such
as Pax7 were not affected (H).
(I and J) Multiplex Nanostring analyses highlighted
loss of multiple genes involved in neural crest
specification. (I) Regions of the embryo dissected
for Nanostring analysis. (J) Graph comparing
transcript levels between control MO and Axud1
MO electroporated sides of the same embryo
assayed by Nanostring analysis. Transcripts
above diagonal lines (upward arrow, in green) were
upregulated; transcripts below diagonal lines
(downward arrow, in red) were downregulated by
loss of Axud1; e.g., depletion of Axud1 drastically
reduced the expression levels of FoxD3, Snai2, and
SoxE genes. Genes within diagonal lines were not
significantly affected above background.
(K) Quantitation of transcript levels averaged be-
tween different Nanostring experiments revealed
downregulation of neural crest specifier genes,
while neural genes and placodal markers were
upregulated in neural folds after loss of Axud1 (see
also Figure S2). Error bars represent SD.
(L) Knockdown of Axud1 (right; green) results in
loss of the neural crest population, which failed to
delaminate from the neural tube as seen in a
midbrain-level transverse section.
(M and N) Neural crest cells were barely detected at later stages as seen in whole-mount views of embryos stained with HNK-1 antibody.
Axud1SBMo, Axud1 splice-blocking morpholino; CoMo, control morpholino; NF, neural fold; NC, neural crest.Consistent with previous results suggesting a role for canoni-
cal Wnt signaling in neural crest induction (Garcı´a-Castro et al.,
2002), we found that loss of either Wnt (Figure 5I) or b-catenin
(Figures S3A–S3I) resulted in downregulation of expression of
FoxD3 as well as other neural crest specifier genes. To firmly
place Axud1 as a downstream effector of the Wnt pathway, we
tested whether it could rescue this loss of neural crest specifica-
tion. The results show that co-electroporation of Axud1 expres-
sion vector with Wnt1 morpholino or Wnt1DN construct restored
FoxD3 expression (Figures 5K and 5L; quantification summa-
rized in Figure 5N). Similarly, the Axud1 expression vector was
sufficient to rescue expression of neural crest specifier genes
Sox9 and Sox10 following Wnt1 loss-of-function (Figures S3J–
S3R). These results suggest that Axud1 is a key player in Wnt1
signal transduction during formation of the neural crest, estab-
lishing its role as a critical effector of Wnt signaling during neural
crest formation.
Axud1 Interacts with Neural Plate Border Genes Pax7
and Msx1 in a Transcriptional Complex to Activate
Neural Crest Gene Expression
Our analysis showed that Axud1 is a downstream effector of Wnt
signaling that is co-expressed with neural plate border genes
Pax7 andMsx1 and directly regulates FoxD3 expression through548 Developmental Cell 34, 544–554, September 14, 2015 ª2015 Elsthe NC1 enhancer. Taken together with our previous data
showing that Pax7 andMsx1 are direct inputs into the FoxD3 en-
hancers (Simo˜es-Costa et al., 2012), we hypothesized that
Axud1 may interact directly with these neural plate border spec-
ifier genes to activate neural crest gene expression.
To test whether Axud1might integrateWnt signaling with tran-
scriptional inputs to control cell identity and behavior, we tested
whether it directly interacts with neural plate border specifiers
in vivo. To this end, we used proximity ligation assays (PLAs)
(So¨derberg et al., 2006), which detect direct protein interactions
in vivo with high specificity and sensitivity, to examine interac-
tions between Axud1 with neural plate border and neural crest
specifier genes. This approach uses two primary antibodies
raised in different species that recognize the target proteins of
interest and species-specific PLA secondary antibodies, each
with an attached unique short DNA strand. Only when the PLA
probes are in close proximity (less than 14 nm) do the DNA
strands interact, resulting in the production of a red punctum
visible in tissue sections (Figure S4). To quantitate the results,
wecountedpuncta in the ventral anddorsal neural tubes (dividing
the neural tube into four regions of the same size in the dorsal-
ventral axis and counting puncta in the two distal regions). The
ventral region of the neural tube, where none of the genes are ex-
pressed,wasused todefine the inherent background levels of theevier Inc.
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Figure 5. Axud1 Acts as a Wnt Effector
during Neural Crest Specification
(A) Immunostaining of transverse sections of HH9
embryos revealed Wnt1 expression in the dorsal
neural tube. DAPI staining was used to visualize
cell nuclei.
(B) In situ hybridization showed that Axud1
expression lies within the Wnt1 positive domain
(dashed outline).
(C and D) Whole-mount dorsal views of embryo in
which control morpholino was electroporated on
the left (blue) and Wnt1 morpholino or b-Catenin
morpholino was electroporated onto the right of
the same embryo.
(F and G) The same embryos as above, showing
effects on expression of Axud1. Inactivation of
Wnt signaling results in downregulation (down-
ward arrow) of Axud1 expression.
(E and H) Conversely, overexpression of Wnt1
(Wnt1 O/E) results in elevation of Axud1 levels in
the neural folds (upward arrow).
(I and J) Whole-mount views of an embryo with
control morpholino on the left and Wnt1 morpho-
lino on the right. Knockdown of Wnt1 resulted in
downregulation of FoxD3 expression.
(K and L) Whole-mount views of an embryo with
control morpholino on the left and Wnt1 morpho-
lino plus Axud1 expression vector on the right,
which was able to rescue FoxD3 expression to
near-normal levels (compare J with L; see also
Figure S3).
(M and N) Quantitation of embryos following
loss of function and rescue assays. The purple
bar in (M) denotes enhancement of Axud1
expression following Wtn1 overexpression,
while the blue and light blue bars represent
strong or mild downregulation following loss-
of-function assays. Error bars in (E) and (G)
represent SD.
HH, Hamburger and Hamilton developmental
stages; b-CatMo, b-cateninmorpholino;Wnt1DNc
Wnt1 DN construct; Wnt1Mo, Wnt1 morpholino;
Wnt1 O/E, Wnt1 overexpression.assay. Using this approach, we examined pair-wise interactions
between Axud1 and Pax7, Axud1 and Msx1, Axud1 and Snai2,
and Axud1 and Ets1, shortly after cranial neural tube closure.
The results showed that Axud1 interacted with both Pax7 and
Msx1 proteins (Figures 6A and 6B) within the newly closed neural
folds. In contrast, Axud1did not interactwith Snai2 or Ets1,which
are also expressed in this domain (Figures 6C–6E). Quantitation
of the results is shown in Figure 6E.
As a secondary test of the interaction between these tran-
scriptional regulators, we used co-immunoprecipitation (IP)
with protein isolated from dorsal neural folds of neurulating em-
bryos. Embryos were electroporated with expression constructs
encoding V5-tagged Axud1 and FLAG-tagged Pax7, Msx1, and
Ets1. In the co-IP assays, Axud1 interacted with both Pax7 as
well as Msx1 (Figure 6F), further suggesting that they are
members of a transcriptional complex responsible for neural
crest gene transcription. In contrast, Ets1 was not able to bring
down Axud1, consistent with the results obtained in the PLA.DevelopmenFinally, we used ChIP analysis to assess the binding of the
neural plate border specifier Msx1 to the FoxD3 NC1 enhancer
in the presence and absence of Axud1. This assay revealed
that, after loss of Axud1, Msx1 failed to occupy the NC1
enhancer element to which it normally binds under control con-
ditions (Figure 6G). Thus, not only does Axud1 directly interact
with neural plate border genes, but it also is necessary for their
recruitment to neural crest enhancers. Taken together, these re-
sults firmly place Axud1 as a downstream effector of canonical
Wnt signaling and critical component of the regulatory complex
that, together with neural plate border transcription factors, initi-
ates formation of the nascent neural crest (Figure 6H).
DISCUSSION
Wnt signaling is used reiteratively throughout neural crest devel-
opment, as it is involved in the activation of multiple transcrip-
tional players that are part of different modules of the NC GRNtal Cell 34, 544–554, September 14, 2015 ª2015 Elsevier Inc. 549
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Figure 6. Axud1 Physically Interacts with
Neural Plate Border Specifiers to Regulate
Neural Crest Specification
(A) PLAs visualized in transverse sections through
the cephalic neural tube of HH9 embryos
demonstrated that Axud1 interacts with Pax7
(positive interactions indicated by red dots; see
also Figure S4).
(B) Similarly, Axud1 interacts with Msx1 (red dots).
(C and D) In contrast, no interactions above
background levels were detected between Axud1
and Snai2 or Ets1.
(E) Quantification of PLA puncta revealed a large
number of interactions in the dorsal neural tube
between Axud1/Pax7 and Axud1/Msx1, whereas
Axud1 interactions with Snai2 and Ets1 were
within background levels.
(F) Tagged constructs were introduced into HH5
embryos and co-IP pulldowns were performed at
HH9. The results showed that Axud1 co-immu-
noprecipitates Pax7 and Msx1, but not Ets1.
(G) ChIP performed in embryos electroporated
with control or Axud1 morpholinos. Under control
conditions (CoMo), Msx1 directly binds to the NC1
enhancer, but was unable to do so in the absence
of Axud1 (Axud1KD), indicating its requirement for
recruitment of the transcriptional complex to the
enhancer.
(H) Model summarizing the results. Axud1 acts
downstream of Wnt/b-catenin to integrate Wnt
signaling with the activity of neural plate border
specifiers by physically interacting with Msx1 and
Pax7 to drive neural crest gene expression in the
dorsal neural folds.(Raible and Ragland, 2005; Sauka-Spengler and Bronner-
Fraser, 2008; Simo˜es-Costa and Bronner, 2015). First, the inter-
play of Wnt signaling with BMPs and FGFs elicits expression of a
group of transcription factors that specify the neural plate border
territory. Subsequently, these neural plate border specifiers
cooperate with Wnt signaling to activate the neural crest speci-
fication program. During neural crest migration, non-canonical
Wnt pathway controls formation of lamellipodia and filopodia
required for cell motility (De Calisto et al., 2005). At later stages,
Wnts also participate in the process of neural crest diversifica-
tion, influencing the fate that neural crest cells will adopt as
they differentiate into distinct derivatives. These multiple roles
of Wnt signaling indicate that its function is context dependent
and dictated by the regulatory state and competence of the
target cells.
Our analyses of the expression, function, and regulation ofWnt
effector, Axud1, reveal a critical role for this transcription factor in
the process of neural crest specification. Axud1 has been shown
to play important roles in several developmental systems, acting
as a tumor suppressor in imaginal disc cells inDrosophila (Glavic
et al., 2009) and in cell-cycle control in the brain of zebrafish em-
bryos (Feijo´o et al., 2009). The finding that Axud knockout mice
have craniofacial defects suggested a possible role for this tran-
scription factor in neural crest development (Schmahl et al.,
2007). Consistent with this possibility, our results show that
integration of Wnt signaling and the neural plate border mod-
ule is Axud1 dependent, such that a transcriptional complex
comprised of Axud1, Pax7, and Msx1 directly activates FoxD3550 Developmental Cell 34, 544–554, September 14, 2015 ª2015 Elsgene expression. Thus, coordination of signaling and transcrip-
tional inputs during neural crest formation takes place at the
trans regulatory level and depends on protein-protein interac-
tions between transcription factors. In particular, Axud1 was
shown to be crucial for the recruitment of this transcriptional
complex to the cis-regulatory element that mediates expression
of cranial FoxD3 (Figure 6H).
Furthermore, our model clarifies how the timing of neural crest
specification is controlled. We previously showed that neural
crest induction in the chick is ongoing during gastrulation (Basch
et al., 2006). In fact, isolation of the presumptive neural crest
domain from the gastrula subsequently led to production of neu-
ral crest cells in the absence of additional signals, suggesting
that the domain was already induced by this time. Loss of
Pax7 blocked the specification process, demonstrating a critical
role for this transcription factor at the neural plate border. How-
ever, it was unclear why signaling and induction occurred at the
gastrula stage whereas neural crest genes like FoxD3, Sox10,
and others did not initiate expression until much later in the
neurula. The present findings help to explain this conundrum
regarding the timing of neural crest induction versus the mani-
festation of neural crest gene expression. Because onset of neu-
ral crest gene expression requires a transcriptional complex
comprised of Pax7, Msx1, and Axud1, absence of any individual
factor results in failure of neural crest formation. While Pax7 and
Msx1 are already present in the neural plate border at gastrula
stages, it is only after onset of Axud1 expression that the neural
crest becomes specified. Thus, our uncovering of Axud1 as aevier Inc.
critical neural crest input helps to resolve the gap in timing
between neural crest induction and onset of specifier gene
expression.
In summary, our results clarify the mechanism by which Wnts
function in neural crest specification and highlight how signaling
pathways are integrated with the transcriptional machinery to
allow for emergence of nascent neural crest cells. The findings
also suggest that the Wnt1-Axud1 cascade is important for
segregation of neural crest precursors from neural and placodal
precursors within the neural plate border territory. In addition to
playing critical roles in neural crest development, both the Wnt
pathway and FoxD3 have been implicated in the maintenance
of pluripotency of embryonic stem cells (Liu and Labosky,
2008;Marson et al., 2008; Sato et al., 2004) and important events
such as the epithelial-to-mesenchymal transition (EMT) (Huber
et al., 2005; Sauka-Spengler and Bronner-Fraser, 2008) and
metastasis (Yook et al., 2006). Thus, our results showing that
Axud1 acts as a molecular link between Wnt signaling and
stem cell factor FoxD3 may reflect a general mechanism that
functions in multiple cellular processes.
EXPERIMENTAL PROCEDURES
Embryos
Fertile chicken eggs were purchased from commercial sources and incubated
at 37C until embryos reached the desired stages. Chicken embryos were
collected according to Chapman et al. (2001) and staged according to the
criteria of Hamburger and Hamilton (1951). For in situ hybridization, embryos
were fixed overnight at 4C in PBS (pH 7.4) containing 4% paraformaldehyde,
dehydrated, and stored in methanol. For immunohistochemistry, embryos
were fixed for 15 min in 4% PFA in PBS and processed immediately.
Whole-Mount In Situ Hybridization
Whole-mount in situ hybridization was performed as described (Wilkinson,
1992), with modifications including more extensive washes and a CHAPS-
based hybridization buffer (Sauka-Spengler et al., 2007). Double-fluorescent
in situ hybridization was performed using the Tyramide TSA system from Perk-
ing Elmer (TSA Plus Cyanine 5 & Fluorescein, NEL754001KT), as described
(Denkers et al., 2004). The templates for mRNA probe synthesis were
the following: FoxD3 (Kos et al., 2001), Pax7 (Basch et al., 2006), Msx1
(ChEST900p21; Boardman et al., 2002), Snail2 (Nieto et al., 1994), Sox9 and
Sox10 (Betancur et al., 2010), Ets1 (ChEST218o8; Boardman et al., 2002),
Wnt1 (Hollyday et al., 1995). Linearized DNA was used to synthesize digoxi-
genin- and fluorescein-labeled antisense probes with Promega RNA polymer-
ases. RNA probes were purified with Illustra ProbeQuant G-50 Micro Columns
(GE Healthcare, 28-9034-08).
Cryosectioning
For histological analysis, embryos were incubated in 5% sucrose (in PBS) for
2 hr at room temperature and subsequently transferred to 15% sucrose and
incubated overnight at 4C. Embryos were incubated in 17% gelatin for 3 hr
at 37C and frozen at 80C; 10–15 mm transverse sections were obtained
by cryosectioning. For imaging, slides were washed twice for 10 min in PBS
with 0.1% Tween, rinsed in double-distilled water, and mounted with Perma-
Fluor Mounting Medium (Thermo Electron Corporation, 434990).
Immunohistochemistry
For whole-mount immunostaining, we used the protocol described by Ezin
et al. (2009). Briefly, after fixation embryos were dissected and washed in
PBSwith 0.3%Triton supplementedwith 0.1%DMSO. Embryoswere blocked
for 2 hr in the same solution supplemented with 10% donkey serum. The
following antibodies were used: Anti-CSRNP1 (Axud1) antibody produced in
rabbit (Sigma, HPA045207, 1:300), anti-WNT1 rabbit polyclonal (Abcam,
b15251, 1:200) and anti-HNK1 (DSHB, 1:10), anti-cleaved caspase-3 antibodyDevelopmen(Cell Signaling, 9661, 1:200), anti-Sox2 (R&D Systems, AF2018, 1:200), and
anti-Six1 (Sigma, HPA001893, 1:200). Secondary antibodies used included
donkey anti-rabbit IGG, or goat anti-mouse IGM, conjugated with Alexa Fluor
488/555/594/647 (1:2,000, Molecular probes). For anti-WNT1 (Serralbo and
Marcelle, 2014), signal was amplified with the Tyramide TSA system from
Perkin Elmer according to the manufacturer’s instruction.
Cloning of Axud1
Axud1 cDNA was PCR amplified from a Gallus cDNA library synthesized
using RNA extracted from stage HH8 dorsal neural folds. Following amplifica-
tion, the PCR product was cloned with the Invitrogen TA Cloning Kit Dual
Promoter (Invitrogen, K2050), sequenced from both ends and used as
template for RNA probe synthesis. To obtain the full-length sequence of
the Axud1 UTR for morpholino design, we performed 50 RACE using the
GeneRacer Kit (Invitrogen, L150201). The gene specific primer used was
AxudRaceInt (50-TCTGCTAACGTGAACTGCCGGGAGGA-30), and the RACE
library was synthesized with RNA obtained from HH8 G. gallus embryonic
heads.
Chick Embryo Electroporation
Chicken embryos were electroporated ex ovo at HH5+ using previously
described techniques (Sauka-Spengler and Barembaum, 2008). Briefly, em-
bryos were dissected from the eggs using a filter paper ring and submersed
in Ringer’s buffer. Morpholinos or expression constructs were subsequently
microinjected in the space between the epiblast and vitelline membrane,
and the embryos were electroporated with platinum electrodes (five 50-ms
pulses of 5.1 V, with an interval of 100 ms between pulses). Following electro-
poration, embryos were cultured at 37C in sterile petri dishes containing fresh
albumen until the desired stages. Embryo survival was >90%, with the vast
majority of the embryos looking healthy prior to fixation. In all experiments,
the two sides of the embryos were electroporated with different reagents.
The left side (control) was injected with biotin-labeled control morpholinos or
control expression vectors. The right side (experimental) was injected with
FITC-labeled targetedmorpholinos and expression vectors. Both morpholinos
are injected at the same time, in the space between the epiblast and the vitel-
line membrane of gastrula stage embryos. At the time of injection, the left and
right domains are sufficiently far apart that the morpholinos do not meet in the
middle. As the embryos undergo neurulation, the two electroporated domains
converge toward the midline. This approach allows for direct comparison
between the two sides of the same embryo. All embryos were screened prior
to further analysis, and embryos with weak or patchy electroporation or with
morphological abnormalities were discarded. Visualization of biotin-labeled
control morpholino was performed by incubating morphants with 1 ng/ml
Streptavidin, Alexa Fluor 647 (Molecular Probes, S32357) in PBS Triton
(0.3%) for 2 hr, followed by three washes of 5 min in PBS with 0.1% Tween
20 (PBST).
Axud1 Loss of Function
Axud1 knockdown experiments were performed by electroporation of
targeted morpholinos (Gene Tools) in the experimental side of the embryos.
We used a FITC-labeled translation-blocking morpholino (AxudTBmo 50-
TTTTCAACACCCCACTCATGGTGAC-30) and a FITC-labeled splice-blocking
morpholino (AxudSBmo 50-CCCCCAATCCAGCCACTCACTTTCC-30), which
was targeted to the Exon2/Intron2 boundary. Morpholinos were electropo-
rated at a concentration of 1.5 mM and supplemented with carrier DNA (pTK-
EGFP; Uchikawa et al., 2003) at a concentration of 1 mg/ml and 10 mM
Tris (pH 8). To assess effects on the NC1 enhancer, we co-electroporated con-
trol and targeted morpholinos with ptk-NC1:mCherry constructs (Simo˜es-
Costa et al., 2012).
Expression Vectors
Axud1 expression vector was built by inserting full-length coding sequence
(1.7 kb) in a pCAGGS-EGFP backbone. The coding sequence of Axud1 was
fused with a 2A linker and mCherry with fusion PCR. This Axud1-2A-mCherry
cassette was then cloned into pCAGGS-EGFP with XhoI and BsrGI. To further
support our knockdown experiments, we also developed an Axud1 DN
construct (Axud1DN). Previous studies indicate that Axud1 acts as an acti-
vator, containing a transactivation domain in the C terminus of the proteintal Cell 34, 544–554, September 14, 2015 ª2015 Elsevier Inc. 551
(Gingras et al., 2007). To generate a DN construct, we inserted fused the
Engrailed Repressor (EnR) (Lee et al., 2004) domain to the C terminus of the
protein, such that it would override its activating properties. The Axud1-EnR
cassette was subsequently subcloned in pCI:H2B-RFP with XhoI and NheI.
Enhancer Analysis
Mutation of Axud1 binding site in the NC1 enhancer was performed as
described (Simo˜es-Costa et al., 2012) with substitution of 20 bp containing
the site by 20 bp of the coding region of GFP (tggagtacaactacaacagc). Ampli-
fied fusion fragments were cloned into ptkeGFP and sequenced to ensure no
additional mutations were present. The mutated enhancer construct driving
GFPwas electroporated as described above into stage HH4 embryos together
with WT enhancer driving mCherry and analyzed for expression of eGFP and
mCherry at stages HH9–10. Co-electroporation with theWT enhancer assures
that differences in intensity are not a result of variation in electroporation effi-
ciency. For qPCRanalysis, we extractedRNA fromembryos co-electroporated
with wtNC1:eGFP andwtNC1:mCherry or mutNC1:eGFP andwtNC1:mCherry
(all at a concentration of 1 mg/ml), according to the manufacturer’s protocol.
cDNA was synthesized using SuperScript III First Strand Synthesis kit (Invitro-
gen) with random primers for RT priming. qPCR was performed using SYBR
Green (Bio-Rad) according to the manufacturer’s instructions. For reference
genes, we used qPCR primers designed for the HPRT1 and GAPDH genes.
Reporter gene levels are represented relative to GAPDH expression.
ChIP
Embryos were electroporated with a pCI:FLAG-Axud1 construct and incu-
bated until stage HH8. For each experiment, 20 embryos were dissected in
Ringer’s solution, and chromatin prepared from dorsal neural folds was immu-
noprecipitated as described (Karafiat et al., 2005; Simo˜es-Costa et al., 2012)
using the SigmaM2 antibody. For endogenous ChIP in Axud1morphants, em-
bryos were electroporated with either control morpholino or the AxudSBmo
at a concentration of 1.5 mM. Chromatin was isolated from dorsal neural
tube regions of HH8 chicken and immunoprecipitated with an Msx1 rabbit
polyclonal antibody (Sigma M0944) and normal rabbit IgGs (ab27478, Abcam)
as controls, as previously described (Simo˜es-Costa et al., 2012).
Nanostring Analysis
To identify targets of Axud1, we compared the expression profiles of control
and morpholino-treated neural folds obtained from the same embryo. Stage
HH5+ chick embryos were electroporated with control morpholino and Ax-
ud1SBmo on the left and right side, respectively (Figure 4J). Both morpholinos
were injected in a concentration of 1.5 mM. Embryos were incubated at 37C
for 12 hr until they reached stage HH8+. The dorsal cranial neural folds from
these embryos weremicrodissected with iridectomy scissors and lysed in Am-
bion lysis buffer (RNAqueous-Micro Kit, AM1931). Control and morpholino-
treated neural folds were processed separately. RNA lysates were hybridized
for 12 hr at 65C to a Nanostring probe set containing 100 probes for neural
crest, placodal, neural, and cell-cycle markers (Hu et al., 2012). Samples were
subsequently processed according to nCounter Prep Station Manual and the
nCounter Digital Analyzer. Sample analysis and normalization were performed
according to the guidelines presented by Barsi et al. (2014).
Wnt Loss and Gain of Function
For disruption of Wnt signaling, we used three different strategies: a DN
Wnt1 vector (Garcı´a-Castro et al., 2002), a splice-blocking Wnt1 morpho-
lino (50-GATGATGCCCCTACGGAGCGGGAAT-30 ) and a translation-blocking
b-catenin morpholino (50-ATGTTCCTTGCTGTGCTCCCAGAAC-30). Activation
of the Wnt pathway was performed with a Wnt1 overexpression vector (Gar-
cı´a-Castro et al., 2002). The morpholinos were electroporated at 1–1.5 mM,
while the DN construct and overexpression vectors were injected at 1 mg/ml
at HH5+. Both the DN construct and theWnt1 expression vector were co-elec-
troporated with pCI-H2BeGFP at 1 mg/ml vector as an electroporation control.
After electroporation, embryos were cultured until HH7-9 and processed for
in situ hybridization as described as above.
PLA
To identify interactions between Axud1 and neural plate border speci-
fiers, we used the DuoLink Fluorescence approach (Sigma, DUO92101).552 Developmental Cell 34, 544–554, September 14, 2015 ª2015 ElsEmbryos were fixed for 15 min in 4% PFA and sectioned and pro-
cessed for immunohistochemistry as described above. The primary anti-
bodies used were the Anti-CSRNP1 (Axud1) antibody produced in rabbit
(Sigma, HPA045207, 1:300) and the following monoclonal mouse anti-
bodies: anti-Msx1/2 (DSHB 4G1, 1:50), anti-Pax7 produced in mouse
(DSHB, 1:50), anti-Snail2 (DSHB 62.1E6, 1:50), anti-Ets1 (Santa Cruz
Biotechnology, sc-56674, 1:300). After washing off excess of primary anti-
body, the assay was carried out according to the manufacturer’s instruc-
tions. PLA-positive puncta were quantified with a fluorescent microscope.
We counted puncta in the ventral and dorsal neural tubes (dividing the
neural tube in four regions of the same size in the dorsal-ventral axis and
counting puncta in the two distal regions). The ventral region of the neural
tube was used to define the background levels of the assay. To facilitate
visualization of the interactions in Figure 6, a fuchsia circle was placed on
each punctum.
Protein IP and Co-IP
For co-IP experiments, the coding sequences of Axud1, Ets1, Msx1, and
Pax7 were fused to V5 and FLAG tags and cloned into pCI:H2B-RFP.
Ets1 (Betancur et al., 2010) and Pax7 (Basch et al., 2000) were PCR ampli-
fied from the referenced templates. Axud1 and Msx1 were PCR amplified
from cDNA. pCI:FLAG-Axud1 was co-electroporated into stage HH4 em-
bryos with PCI:V5-Axud1, PCI:V5-Ets1, PCI:V5-Msx1, and PCI:V5-Pax7
constructs. Embryos were incubated until stage HH8, when their heads
were dissected and used for preparation for IP. Electroporation efficiency
was confirmed by RFP expression prior to dissection. Nuclear extracts
were obtained by incubating and lysing embryonic heads (n = 30 per
sample) in cell lysis buffer (10 mM HEPES [pH 7.9], 1.5 mM MgCl2,
10 mM KCl solution). After centrifugation for 5 min at 2,500 g and 4C,
the pellet was resuspended in 20 mM HEPES, 1.5 mM MgCl2, 0.2 mM
EDTA, 20% glycerol, and 420 mM KCL, supplemented with DTT, PMSF,
and protease inhibitor cocktail (Roche Applied Science, 11697498001).
Samples were incubated for 20 min on ice and centrifuged for 3 min at
16,000 g and 4C. For co-IP, nuclear protein extract was incubated in
modified RIPA buffer with Dynabeads conjugated with the M2 anti-Flag
antibody (Sigma-Aldrich, A8592) in rotation for 3 hr. Magnetic beads
washed five times using modified RIPA, and proteins were eluted in
Laemmli buffer. For western blotting, proteins were separated by electro-
poration on SDS-PAGE gels for standard protein samples. Following
immunoblotting on nitrocellulose membranes, bands were visualized by
chemiluminescence (GE Healthcare, RPN2232). In co-IP experiments, V5
Mouse Monoclonal Antibody conjugated with HRP (Promega, R961-25)
was used for target protein visualization.
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